Evidence map›Paper›PMID 38525945›Full record

ArticleHuman vaccines & immunotherapeutics2024

Production of monoclonal antibodies against botulinum neurotoxin in

Kornchanok Sangprasat, Christine Joy I Bulaon, Kaewta Rattanapisit, Theerakarn Srisangsung, Perawat Jirarojwattana, Apidsada Wongwatanasin, Waranyoo Phoolcharoen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Human vaccines & immunotherapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Biotechnology reports (Amsterdam, Netherlands) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Kornchanok SangprasatCenter of Excellence in Plant-Produced Pharmaceuticals, Chulalongkorn University, Bangkok, Thailand.
Christine Joy I BulaonDepartment of Research and Development, Baiya Phytopharm Co. Ltd, Bangkok, Thailand.
Kaewta RattanapisitDepartment of Research and Development, Baiya Phytopharm Co. Ltd, Bangkok, Thailand.
Theerakarn SrisangsungCenter of Excellence in Plant-Produced Pharmaceuticals, Chulalongkorn University, Bangkok, Thailand.
Perawat JirarojwattanaDepartment of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
Apidsada WongwatanasinDepartment of Research and Development, Baiya Phytopharm Co. Ltd, Bangkok, Thailand.
Waranyoo PhoolcharoenCenter of Excellence in Plant-Produced Pharmaceuticals, Chulalongkorn University, Bangkok, Thailand.ORCID 0000-0001-5958-7406
Chulalongkorn University · THChina National Pharmaceutical Group Corporation (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Botulism is a fatal neurologic disease caused by the botulinum toxin (BoNT) produced by

Indexed as

AntitoxinsBotulinum Toxins, Type ABotulismAnimalsAntibodies, MonoclonalHorsesHumansNicotianaAntibodies, MonoclonalAntitoxinsBotulinum Toxins, Type Abotulinum neurotoxinBotulismClostridium botulinummonoclonal antibodyNicotiana benthamiana

Identifiers

PMID38525945
PMCPMC10965107
OpenAlexW4393160052

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.